Activation of the WNT/β-catenin pathway attenuates experimental emphysema

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 6, 2011, Pages 723-733

  Kneidinger, Nikolaus ^a   Yildirim, Ali Önder ^b   Callegari, Jens ^b   Takenaka, Shinji ^b   Stein, Maria Magdalena ^b   Dumitrascu, Rio ^a   Bohla, Alexander ^b   Bracke, Ken R ^c   Morty, Rory E ^a   Brusselle, Guy G ^c   Schermuly, Ralph Theo ^a   Eickelberg, Oliver ^b   Königshoff, Melanie ^b  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Chronic obstructive pulmonary disease; Emphysema; Lung development; WNT

Indexed keywords

BETA CATENIN; COLLAGEN; ELASTASE; LITHIUM CHLORIDE; WNT PROTEIN;

ANIMAL TISSUE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COLLAGEN SYNTHESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG DEVELOPMENT; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG STRUCTURE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

ADULT; ANIMALS; BETA CATENIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SIGNAL TRANSDUCTION; TISSUE DONORS; WNT PROTEINS; WNT1 PROTEIN;

EID: 79952715657     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200910-1560OC     Document Type: Article

References (67)

1. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-1259.
2. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117:5S-9S.
3. Barnes PJ. Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc 2008;5:857-864.
4. Chen ZH, Kim HP, Ryter SW, Choi AM. Identifying targets for COPD treatment through gene expression analyses. Int J Chron Obstruct Pulmon Dis 2008;3:359-370.
5. Lamprecht B, Schirnhofer L, Kaiser B, Buist S, Studnicka M. Nonreversible airway obstruction in never smokers: results from the Austrian BOLD study. Respir Med 2008;102:1833-1838.
6. Walter R, Gottlieb DJ, O'Connor GT. Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease. Environ Health Perspect 2000;108:733-742.
7. Tuder RM, Yoshida T, Arap W, Pasqualini R, Petrache I. State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc 2006;3:503-510.
8. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes MMP12-dependent emphysema. Nature 2003;422:169-173.
9. de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, van Krieken JH. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1951-1957. (Pubitemid 29008838)
10. Minai OA, Benditt J, Martinez FJ. Natural history of emphysema. Proc Am Thorac Soc 2008;5:468-474.
11. Goss AM, Tian Y, Tsukiyama T, Cohen ED, Zhou D, Lu MM, Yamaguchi TP, Morrisey EE. WNT2/2b and beta-catenin signaling are necessary and sufficient to specify lung progenitors in the foregut. Dev Cell 2009;17:290-298.
12. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 2004;5:691-701. (Pubitemid 39150127)
13. Konigshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, Rose F, Fink L, Seeger W, Schaefer L, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 2009;119:772-787.
14. Konigshoff M, Eickelberg O. WNT signaling in lung disease: a failure or a regeneration signal? Am J Respir Cell Mol Biol 2010;42:21-31.
15. Selman M, Pardo A, Barrera L, Estrada A, Watson SR, Wilson K, Aziz N, Kaminski N, Zlotnik A. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 2006;173:188-198. (Pubitemid 43187891)
16. Chilosi M, Poletti V, Zamo A, Lestani M, Montagna L, Piccoli P, Pedron S, Bertaso M, Scarpa A, Murer B, et al. Aberrant WNT/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003;162:1495-1502. (Pubitemid 36512831)
17. Logan CY, Nusse R. The WNT signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004;20:781-810. (Pubitemid 39488658)
18. Cadigan KM, Liu YI. WNT signaling: complexity at the surface. J Cell Sci 2006;119:395-402.
19. Stripp BR, Reynolds SD. Maintenance and repair of the bronchiolar epithelium. Proc Am Thorac Soc 2008;5:328-333. (Pubitemid 351520679)
20. Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010;298:L715-L731.
21. Konigshoff M, Balsara N, Pfaff EM, Kramer M, Chrobak I, Seeger W, Eickelberg O. Functional WNT signaling is increased in idiopathic pulmonary fibrosis. PLoS ONE 2008;3:e2142.
22. Liu L, Carron B, Yee HT, Yie TA, Hajjou M, Rom W. WNT pathway in pulmonary fibrosis in the bleomycin mouse model. J Environ Pathol Toxicol Oncol 2009;28:99-108.
23. Kneidinger N, Königshoff M, Becker S, Eickelberg O. Expression and activity of WNT/beta-catenin signalling in COPD. Am J Respir Crit Care Med 2009;179:A1004. (abstract).
24. DasGupta R, Fuchs E. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 1999;126:4557-4568.
25. Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS. Activation of the WNT signaling pathway: a molecular mechanism for lithium action. Dev Biol 1997;185:82-91. (Pubitemid 27244219)
26. Fehrenbach H, Voswinckel R, Michl V, Mehling T, Fehrenbach A, Seeger W, Nyengaard JR. Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice. Eur Respir J 2008;31:515-522.
27. Bilic J, Huang YL, Davidson G, Zimmermann T, Cruciat CM, Bienz M, Niehrs C. WNT induces Lrp6 signalosomes and promotes dishevelled-dependent lrp6 phosphorylation. Science 2007;316:1619-1622. (Pubitemid 46982035)
28. Forde JE, Dale TC. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci 2007;64:1930-1944. (Pubitemid 47094432)
29. Henderson WR Jr, Chi EY, Ye X, Nguyen C, Tien YT, Zhou B, Borok Z, Knight DA, Kahn M. Inhibition of WNT/beta-catenin/Creb binding protein (CBP) signaling reverses pulmonary fibrosis. Proc Natl Acad Sci USA 2010;107:14309-14314.
30. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007;30:993-1013. (Pubitemid 351194805)
31. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004;364:709-721. (Pubitemid 39140629)
32. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med 2007;28:479-513. (Pubitemid 47284592)
33. Rennard SI, Togo S, Holz O. Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema. Proc Am Thorac Soc 2006;3:703-708. (Pubitemid 44788228)
34. Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc 2008;5:475-477. (Pubitemid 351669173)
35. Henson PM, Vandivier RW, Douglas IS. Cell death, remodeling, and repair in chronic obstructive pulmonary disease? Proc Am Thorac Soc 2006;3:713-717.
36. Shi W, Bellusci S, Warburton D. Lung development and adult lung diseases. Chest 2007;132:651-656. (Pubitemid 47282400)
37. Shu W, Jiang YQ, Lu MM, Morrisey EE. WNT7b regulates mesenchymal proliferation and vascular development in the lung. Development 2002;129:4831-4842. (Pubitemid 35277208)
38. Cardoso WV, Lu J. Regulation of early lung morphogenesis: questions, facts and controversies. Development 2006;133:1611-1624. (Pubitemid 43810969)
39. Flozak AS, Lam AP, Russell S, Jain M, Peled ON, Sheppard KA, Beri R, Mutlu GM, Budinger GR, Gottardi CJ. Beta-catenin/T-cell factor signaling is activated during lung injury and promotes the survival and migration of alveolar epithelial cells. J Biol Chem 2010;285:3157-3167.
40. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. WNT/beta-catenin/TCF signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002;22:1172-1183. (Pubitemid 34094853)
41. Pfaff EM, Becker S, Gunther A, Konigshoff M. Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis. Eur Respir J 2010 Jul 22. [Epub ahead of print]
42. Foronjy R, Imai K, Shiomi T, Mercer B, Sklepkiewicz P, Thankachen J, Bodine P, D'Armiento J. The divergent roles of secreted frizzled related protein-1 (SFRP1) in lung morphogenesis and emphysema. Am J Pathol 2010;177:598-607.
43. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2008;295:L1-L15.
44. Blacquière MJ, Timens W, van den Berg A, Geerlings M, Postma DS, Hylkema MN. Maternal smoking during pregnancy decreases Wnt signalling in neonatal mice. Thorax 2010;65:553-554.
45. Mosimann C, Hausmann G, Basler K. Beta-catenin hits chromatin: regulation of WNT target gene activation. Nat Rev Mol Cell Biol 2009;10:276-286.
46. Doble BW, Woodgett JR. Gsk-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003;116:1175-1186. (Pubitemid 36410657)
47. Lucey EC, Goldstein RH, Stone PJ, Snider GL. Remodeling of alveolar walls after elastase treatment of hamsters. Results of elastin and collagen MMA in situ hybridization. Am J Respir Crit Care Med 1998;158:555-564. (Pubitemid 28378187)
48. Rubio ML, Martin-Mosquero MC, Ortega M, Peces-Barba G, Gonzalez-Mangado N. Oral N-acetylcysteine attenuates elastase-induced pulmonary emphysema in rats. Chest 2004;125:1500-1506. (Pubitemid 38501368)
49. Yokohori N, Aoshiba K, Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004;125:626-632. (Pubitemid 38223645)
50. Verkman AS. Role of aquaporins in lung liquid physiology. Respir Physiol Neurobiol 2007;159:324-330. (Pubitemid 350116730)
51. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008;31:1334-1356.
52. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003;22:672-688. (Pubitemid 37258549)
53. Douglas IS, Diaz del Valle F, Winn RA, Voelkel NF. Beta-catenin in the fibroproliferative response to acute lung injury. Am J Respir Cell Mol Biol 2006;34:274-285. (Pubitemid 43320708)
54. Teng Y, Wang X, Wang Y, Ma D. WNT/beta-catenin signaling regulates cancer stem cells in lung cancer a549 cells. Biochem Biophys Res Commun 2010;392:373-379.
55. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
56. You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, Reguart N, Moody TW, Kitajewski J, McCormick F, et al. Inhibition of WNT-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 2004;23:6170-6174.
57. Vuga LJ, Ben-Yehudah A, Kovkarova-Naumovski E, Oriss T, Gibson KF, Feghali-Bostwick C, Kaminski N. WNT5a is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol 2009;41:583-589.
58. Chilosi M, Zamo A, Doglioni C, Reghellin D, Lestani M, Montagna L, Pedron S, Ennas MG, Cancellieri A, Murer B, et al. Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res 2006;7:95.
59. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823-835. (Pubitemid 40806415)
60. Stripp BR, Shapiro SD. Stem cells in lung disease, repair, and the potential for therapeutic interventions: state-of-the-art and future challenges. Am J Respir Cell Mol Biol 2006;34:517-518.
61. Giangreco A, Reynolds SD, Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 2002;161:173-182. (Pubitemid 34760783)
62. Loebinger MR, Janes SM. Stem cells for lung disease. Chest 2007;132:279-285. (Pubitemid 47068232)
63. Zhang Y, Goss AM, Cohen ED, Kadzik R, Lepore JJ, Muthukumaraswamy K, Yang J, DeMayo FJ, Whitsett JA, Parmacek MS, et al. GATA6-WNT pathway required for epithelial stem cell development and airway regeneration. Nat Genet 2008;40:862-870. (Pubitemid 351913647)
64. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, Weissman IL. A role for WNT signalling in self-renewal of haematopoietic stem cells. Nature 2003;423:409-414. (Pubitemid 36626987)
65. Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL, Weidinger G, Puder M, Daley GQ, Moon RT, et al. Genetic interaction of PGE2 and WNT signaling regulates developmental specification of stem cells and regeneration. Cell 2009;136:1136-1147.
66. Houghton AM, Mouded M, Shapiro SD. Common origins of lung cancer and COPD. Nat Med 2008;14:1023-1024.
67. Mazieres J, He B, You L, Xu Z, Jablons DM. WNT signaling in lung cancer. Cancer Lett 2005;222:1-10. (Pubitemid 40544841)